OBJECTIVE:To investigate the clinical evolution of coronavirus disease 2019 (COVID-19) in hospitalized pregnant women and potential factors associated with severe maternal outcomes.METHODS:We designed a prospective multicenter cohort study of pregnant women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection who were admitted to 12 Italian maternity hospitals between February 23 and March 28, 2020. Clinical records, laboratory and radiologic examinations, and pregnancy outcomes were collected. A subgroup of patients with severe disease was identified based on intensive care unit (ICU) admission, delivery for respiratory compromise, or both.RESULTS:Seventy-seven patients were included, 14 of whom had severe disease (18%). Two thirds of the patients in the cohort were admitted during the third trimester, and 84% were symptomatic on admission. Eleven patients underwent urgent delivery for respiratory compromise (16%), and six were admitted to the ICU (8%). One woman received extracorporeal membrane oxygenation; no deaths occurred. Preterm delivery occurred in 12% of patients, and nine newborns were admitted to the neonatal intensive care unit. Patients in the severe subgroup had significantly higher pregestational body mass indexes (BMIs) and heart and respiratory rates and a greater frequency of fever or dyspnea on admission compared with women with a nonsevere disease evolution.CONCLUSION:In our cohort, one in five women hospitalized with COVID-19 infection delivered urgently for respiratory compromise or were admitted to the ICU. None, however, died. Increased pregestational BMI and abnormal heart and respiratory rates on admission were associated with severe disease.

Clinical findings and disease severity in hospitalized pregnant women with coronavirus disease 2019 (COVID-19) / V.M. Savasi, F. Parisi, L. Patane, E. Ferrazzi, L. Frigerio, A. Pellegrino, A. Spinillo, S. Tateo, M. Ottoboni, P. Veronese, F. Petraglia, P. Vergani, F. Facchinetti, D. Spazzini, I. Cetin. - In: OBSTETRICS AND GYNECOLOGY. - ISSN 0029-7844. - 136:2(2020 Aug), pp. 252-258. [10.1097/AOG.0000000000003979]

Clinical findings and disease severity in hospitalized pregnant women with coronavirus disease 2019 (COVID-19)

V.M. Savasi;F. Parisi
;
E. Ferrazzi;I. Cetin
2020

Abstract

OBJECTIVE:To investigate the clinical evolution of coronavirus disease 2019 (COVID-19) in hospitalized pregnant women and potential factors associated with severe maternal outcomes.METHODS:We designed a prospective multicenter cohort study of pregnant women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection who were admitted to 12 Italian maternity hospitals between February 23 and March 28, 2020. Clinical records, laboratory and radiologic examinations, and pregnancy outcomes were collected. A subgroup of patients with severe disease was identified based on intensive care unit (ICU) admission, delivery for respiratory compromise, or both.RESULTS:Seventy-seven patients were included, 14 of whom had severe disease (18%). Two thirds of the patients in the cohort were admitted during the third trimester, and 84% were symptomatic on admission. Eleven patients underwent urgent delivery for respiratory compromise (16%), and six were admitted to the ICU (8%). One woman received extracorporeal membrane oxygenation; no deaths occurred. Preterm delivery occurred in 12% of patients, and nine newborns were admitted to the neonatal intensive care unit. Patients in the severe subgroup had significantly higher pregestational body mass indexes (BMIs) and heart and respiratory rates and a greater frequency of fever or dyspnea on admission compared with women with a nonsevere disease evolution.CONCLUSION:In our cohort, one in five women hospitalized with COVID-19 infection delivered urgently for respiratory compromise or were admitted to the ICU. None, however, died. Increased pregestational BMI and abnormal heart and respiratory rates on admission were associated with severe disease.
Settore MED/40 - Ginecologia e Ostetricia
Settore MED/09 - Medicina Interna
ago-2020
19-mag-2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
Savasi VM 2020_postprint.pdf

accesso aperto

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 192.79 kB
Formato Adobe PDF
192.79 kB Adobe PDF Visualizza/Apri
Clinical_Findings_and_Disease_Severity_in.6.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 654.76 kB
Formato Adobe PDF
654.76 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/791987
Citazioni
  • ???jsp.display-item.citation.pmc??? 99
  • Scopus 131
  • ???jsp.display-item.citation.isi??? 116
social impact